TG Therapeutics (TGTX) Unit Enters Sublicense Agreement w/ Checkpoint Therapeutics for BET Inhibitors
Tweet Send to a Friend
TG Therapeutics, Inc. (Nasdaq: TGTX), announced that as part of a broader agreement with Jubilant Biosys (“Jubilant”), an Indian biotechnology ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
